Clinical Trials
Since its inception, the MMRC has facilitated 19 Phase I and Phase II clinical trials. These trials include several combination approaches and novel compounds that are thought to be active against high-priority targets.
2008
- Phase II Wyeth Torisel-Velcade
- Phase I Elotuzumab-Revlimid-Dex
2007
2005 – 2006
|